Abstract
Introduction
The PRECE is a model predicting the risk of extracapsular extension (ECE) of prostate cancer: it has been developed on more than 6000 patients who underwent robotic radical prostatectomy (RARP) at the Global Robotic Institute, FL, USA. Up to now, it is the single tool predicting either the side and the amount of ECE. The model has a free user-friendly interface and is made up from simple and available covariates, namely age, PSA, cT, GS and percent of positive core, the latter topographically distributed within the prostate gland. Despite the successful performance at internal validation, the model is still lacking an external validation (EV). The aim of the paper is to externally validate the PRECE model on an Italian cohort of patients elected to RARP.
Methods
269 prostatic lobes from 141 patients represented the validation dataset. The EV was performed with the receiver operating characteristics (ROC) curves and calibration, to address the ability of PRECE to discriminate between patients with or without ECE.
Results
Overall, an ECE was found in 91 out of the 269 prostatic lobes (34%). Twenty-five patients out of pT3 had a bilateral ECE. The ROC curve showed an AUC of 0.80 (95% CI 0.74–0.85). Sensitivity and specificity were 77% and 69%, respectively. The model showed an acceptable calibration with tendency towards overestimation.
Conclusions
From the current EV, the PRECE displays a good predictive performance to discriminate between cases with and without ECE; despite preliminary, outcomes may support the generalizability of the model in dataset other than the development one.
Similar content being viewed by others
References
EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2022. ISBN 978-94-92671-16-5
Fasulo V, Buffi NM, Regis F, Paciotti M, Persico F, Maffei D, Uleri A, Saita A, Casale P, Hurle R, Lazzeri M, Guazzoni G, Lughezzani G (2022) Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional study. World J Urol. https://doi.org/10.1007/s00345-021-03890-4
Patel V, Sandri M, Grasso AAC, De Lorenzis E, Palmisano F, Albo G, Coelho RF, Mottrie A, Harvey T, Kameh D, Palayapalayam H, Wiklund P, Bosari S, Puliatti S, Zuccolotto P, Bianchi G, Rocco B (2018) A novel tool for predicting extracapsular extension during graded partial nerve sparing in radical prostatectomy. BJU Int 121(3):373–382. https://doi.org/10.1111/bju.14026 (Epub 22 Oct 2017)
Hosmer JDW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression, 3rd edn. Wiley, Hoboken
Steyerberg EW, Vickers AJ, Cook NR et al (2010) Assessing the performance of prediction models: a framework for some traditional and novel measures. Epidemiology 21:128–138
Van Hoorde K, Van Huffel S, Timmerman D, Bourne T, Van Calster B (2015) A spline-based tool to assess and visualize the calibration of multiclass risk predictions. J Biomed Inform 54:283–293
Gandaglia G, Ploussard G, Valerio M et al (2020) The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging-targeted and concomitant systematic biopsies for the prediction of adverse pathological features in prostate cancer patients undergoing radical prostatectomy. Eur Urol 77:733–741
Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Quackels T, Assenmacher G, Simone G, Van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Peltier A, Roumeguère T, Albisinni S (2021) External validation of a multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension and seminal vesicle invasion in prostate cancer patients undergoing radical prostatectomy. Eur Urol 79(2):180–185. https://doi.org/10.1016/j.eururo.2020.09.037 (Epub 3 Oct 2020)
Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG 3rd, Briganti A, Montorsi F, Tewari AK (2018) Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer. BJU Int 122(6):1025–1033. https://doi.org/10.1111/bju.14353
Giganti F, Coppola A, Ambrosi A, Ravelli S, Esposito A, Freschi M, Briganti A, Scattoni V, Salonia A, Gallina A, Dehò F, Cardone G, Balconi G, Gaboardi F, Montorsi F, Maschio AD, De Cobelli F (2016) Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: development and external validation of a nomogram of clinical use. Urol Oncol 34(7):291.e9-291.e17. https://doi.org/10.1016/j.urolonc.2016.02.015 (Epub 15 Mar 2016)
Chen Y, Yu W, Fan Y, Zhou L, Yang Y, Wang H, Jiang Y, Wang X, Wu S, Jin J (2017) Development and comparison of a Chinese nomogram adding multi-parametric MRI information for predicting extracapsular extension of prostate cancer. Oncotarget 8(13):22095–22103. https://doi.org/10.18632/oncotarget.11559
Nyarangi-Dix J, Wiesenfarth M, Bonekamp D, Hitthaler B, Schütz V, Dieffenbacher S, Mueller-Wolf M, Roth W, Stenzinger A, Duensing S, Roethke M, Teber D, Schlemmer HP, Hohenfellner M, Radtke JP (2020) Combined clinical parameters and multiparametric magnetic resonance imaging for the prediction of extraprostatic disease—a risk model for patient-tailored risk stratification when planning radical prostatectomy. Eur Urol Focus 6(6):1205–1212. https://doi.org/10.1016/j.euf.2018.11.004 (Epub 23 Nov 2018)
Wibmer A, Vargas HA, Donahue TF, Zheng J, Moskowitz C, Eastham J, Sala E, Hricak H (2015) Diagnosis of extracapsular extension of prostate cancer on prostate MRI: impact of second-opinion readings by subspecialized genitourinary oncologic radiologists. AJR Am J Roentgenol 205(1):W73–W78. https://doi.org/10.2214/AJR.14.13600
Leyh-Bannurah Leyh-Bannurah SR, Kachanov M, Karakiewicz PI, Beyersdorff D, Pompe RS, Oh-Hohenhorst SJ, Fisch M, Maurer T, Graefen M, Budäus L (2021) Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer. World J Urol 39(1):81–88. https://doi.org/10.1007/s00345-020-03176-1
Zapała P, Dybowski B, Bres-Niewada E, Lorenc T, Powała A, Lewandowski Z, Gołębiowski M, Radziszewski P (2019) Predicting side-specific prostate cancer extracapsular extension: a simple decision rule of PSA, biopsy, and MRI parameters. Int Urol Nephrol 51(9):1545–1552. https://doi.org/10.1007/s11255-019-02195-1 (Epub 10 Jun 2019)
Alves JR, Muglia VF, Lucchesi FR, Faria RAOG, Alcantara-Quispe C, Vazquez VL, Reis RB, Faria EF (2020) Independent external validation of nomogram to predict extracapsular extension in patients with prostate cancer. Eur Radiol 30(9):5004–5010. https://doi.org/10.1007/s00330-020-06839-0
Sighinolfi MC, Sandri M, Torricelli P, Ligabue G, Fiocchi F, Scialpi M, Eissa A, Reggiani Bonetti L, Puliatti S, Bianchi G, Rocco B (2019) External validation of a novel side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer: preliminary outcomes on a series diagnosed with multiparametric magnetic resonance imaging-targeted plus systematic saturation biopsy. BJU Int 124(2):192–194. https://doi.org/10.1111/bju.14665
Soeterik TFW, van Melick HHE, Dijksman LM, Küsters-Vandevelde H, Stomps S, Schoots IG, Biesma DH, Witjes JA, van Basten JA (2020) Development and external validation of a novel nomogram to predict side-specific extraprostatic extension in patients with prostate cancer undergoing radical prostatectomy. Eur Urol Oncol. https://doi.org/10.1016/j.euo.2020.08.008
de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM (2016) Accuracy of magnetic resonance imaging for local staging of prostate cancer: a diagnostic meta-analysis. Eur Urol 70:233–245
Rocco B, Sighinolfi MC, Sandri M, Eissa A, Elsherbiny A, Zoeir A, Tadzia H, Palayapalayam H, Kameh D, Coelho R, Puliatti S, Zuccolotto P, Montironi R, Wiklund P, Micali S, Bianchi G, Patel V (2019) Is extraprostatic extension of cancer predictable? A review of predictive tools and an external validation based on a large and a single center cohort of prostate cancer patients. Urology 129:8–20. https://doi.org/10.1016/j.urology.2019.03.019 (Epub 28 Mar 2019)
Toll DB, Janssen KJM, Vergouwe Y, Moons KGM (2008) Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol 61:1085–1094
Author information
Authors and Affiliations
Contributions
SMC: project development and manuscript writing. AS: data collection. CA: data collection. SL: data collection. CT: data collection. SM: data analysis. MS: manuscript editing. TS: manuscript editing. NJ: manuscript editing. CMM: manuscript editing. SB: manuscript editing. PV: project development. RB: project development and manuscript editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors disclose any potential conflict of interest.
Disclosure
Registry and the Registration No. of the study/trial: N/A.
Ethical approval
The retrospective assessment of factors predicting prostate cancer aggressiveness (including radiological, pathological and laboratories variables) was approved by the local Ethic Committee (982/2018/OSS/AOUMO).
Informed consent
N/A.
Research involving human and animal rights
Animal study: N/A.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sighinolfi, M.C., Assumma, S., Cassani, A. et al. Pre-operative prediction of extracapsular extension of prostate cancer: first external validation of the PRECE model on an independent dataset. Int Urol Nephrol 55, 93–97 (2023). https://doi.org/10.1007/s11255-022-03365-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-022-03365-4